These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 23088463)
1. Clinical significance of CYFRA21-1, Scc-Ag and telomerase activity in serum and pleural effusion of patients with squamous-cell lung cancer. Liu L; Liu B; Zhu LL; Zhang W; Li Y Bioanalysis; 2012 Oct; 4(19):2367-74. PubMed ID: 23088463 [TBL] [Abstract][Full Text] [Related]
2. [Clinical value of combined determination of serum and pleural effusion level of CEA,CYFRA21-1, TPS in the diagnosis of lung cancer]. Huang F; Wang XL; Yang L; Yin BX; Geng Y; Li TT Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Apr; 24(4):370-2. PubMed ID: 18394347 [TBL] [Abstract][Full Text] [Related]
3. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer. Mizuguchi S; Nishiyama N; Iwata T; Nishida T; Izumi N; Tsukioka T; Inoue K; Uenishi T; Wakasa K; Suehiro S Lung Cancer; 2007 Dec; 58(3):369-75. PubMed ID: 17697728 [TBL] [Abstract][Full Text] [Related]
4. [Clinical usefulness of a new tumor marker CYFRA21-1 in patients with lung cancer]. Li R; Li R; Wang Y Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):26-9. PubMed ID: 11263296 [TBL] [Abstract][Full Text] [Related]
5. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions. Li CS; Cheng BC; Ge W; Gao JF Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612 [TBL] [Abstract][Full Text] [Related]
6. [Diagnostic significance of combining telomerase activity with CYFRA21-1 level in differentiating malignant pleural effusion caused by lung cancer from benign pleural effusion]. Li H; Fu J; Xiu Y; Zhou Q Zhongguo Fei Ai Za Zhi; 2010 Jun; 13(6):652-4. PubMed ID: 20681457 [TBL] [Abstract][Full Text] [Related]
7. [The diagnostic significance of single or combination lung cancer-related serum biomarkers in high risk lung cancer patients]. Ni J; Guo Z; Zhang L Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):25-30. PubMed ID: 26796649 [TBL] [Abstract][Full Text] [Related]
8. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited. Ma S; Shen L; Qian N; Chen K Cancer Biomark; 2011-2012; 10(3-4):155-62. PubMed ID: 22674301 [TBL] [Abstract][Full Text] [Related]
9. [Detection and diagnostic value of serum carcinoembryonic antigen and cytokeratin 19 fragment in lung cancer patients]. Hang ZQ; Zheng MF; Huang JH Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):847-9. PubMed ID: 22335951 [TBL] [Abstract][Full Text] [Related]
10. [Significance of CEA, SCC and Cyfra21-1 serum test in esophageal cancer]. Mao YS; Zhang DC; Zhao XH; Wang LJ; Qi J; Li XX Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):457-60. PubMed ID: 14575569 [TBL] [Abstract][Full Text] [Related]
11. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis]. Chen F; Li WM; Wang DM; Gao SS; Bao Y; Chen WB; Liu D Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326 [TBL] [Abstract][Full Text] [Related]
12. The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix. Liu CZ; Zeng HX; Zhao JJ; Rong Y; Mo ZL; Li LA; Zhang JQ Int J Gynecol Cancer; 2017 Jun; 27(5):994-1000. PubMed ID: 28498239 [TBL] [Abstract][Full Text] [Related]
13. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis. Cui C; Sun X; Zhang J; Han D; Gu J J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270 [TBL] [Abstract][Full Text] [Related]
14. [Usefulness of CYFRA21-1 as a tumor marker of non-small-cell lung cancer]. Tan Y; Zhang P; Zheng C Zhonghua Zhong Liu Za Zhi; 1999 Jul; 21(4):287-9. PubMed ID: 11776818 [TBL] [Abstract][Full Text] [Related]
15. Comparison of pre-treatment CYFRA 21 - 1 and SCC-Antigen assay in primary cervical carcinoma - a preliminary report. Puthucode-Easwaran S; Naik R; Athavale R; Handley G; Lopes A; Godfrey K; Hatem M J Obstet Gynaecol; 2005 Jul; 25(5):486-8. PubMed ID: 16183586 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of combined examination of pretreatment serum CYFRA21-1 and SCCAg in cervical cancer patients. Xiong Y; Peng XP; Liang LZ; Zheng M; Li JD Ai Zheng; 2009 Jan; 28(1):64-7. PubMed ID: 19448420 [TBL] [Abstract][Full Text] [Related]
17. [Detection of serum CK19-2G2 and Cyfra21-1 protein and comparison of their diagnostic value for lung cancer]. Gao J; Wang H; Qi J Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):930-2. PubMed ID: 19173996 [TBL] [Abstract][Full Text] [Related]
18. [Value of tumor markers series of hydrothorax in differential diagnosis of pleural effusion]. Liu YQ; Zhang HL; Gao WJ; Lan X; Yuan BJ; Zou JM Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Jan; 26(1):34-8. PubMed ID: 18302890 [TBL] [Abstract][Full Text] [Related]
19. Serum cyfra21-1 as a biomarker in patients with nonsmall cell lung cancer. Zhao H; Shi X; Liu J; Chen Z; Wang G J Cancer Res Ther; 2014 Nov; 10 Suppl():C215-7. PubMed ID: 25450285 [TBL] [Abstract][Full Text] [Related]
20. [Diagnostic utility of carcinoembryonic antigen, neuron-specific enolase and squamous cell carcinoma antigen in malignant pleural effusion]. Sánchez de Cos Escuín J; López Parra S; Disdier Vicente C; Martín Vicente MJ; Masa Jiménez JF; Domínguez Retortillo C An Med Interna; 1996 Aug; 13(8):369-73. PubMed ID: 8983362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]